Last updated on November 2018

A Phase II Study of M2951 in Systemic Lupus Erythematosus (SLE)

Brief description of study

M2951 is an investigational drug under evaluation for treatment of autoimmune and inflammatory disorders. The purpose of the study is to assess the Safety and Efficacy of M2951 in Subjects with Systemic Lupus Erythematosus (SLE)

Clinical Study Identifier: NCT02975336

Contact Investigators or Research Sites near you

Start Over

Miguel Saavedra Salinas

Clinical Research Institute S.C.
Tlalnepantla, Mexico
  Connect »

US Medical Information

Unidad de Investigacion de las Enfermedades Reumaticas
Cuauhtemoc, Mexico
  Connect »

Favio Edmundo Enriquez Sosa

Clinstile, S.A. de C.V.
Mexico, Mexico
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.